648 related articles for article (PubMed ID: 27575488)
1. Comparison of Outcomes before and after Ohio's Law Mandating Use of the FDA-Approved Protocol for Medication Abortion: A Retrospective Cohort Study.
Upadhyay UD; Johns NE; Combellick SL; Kohn JE; Keder LM; Roberts SC
PLoS Med; 2016 Aug; 13(8):e1002110. PubMed ID: 27575488
[TBL] [Abstract][Full Text] [Related]
2. Outcomes During Early Implementation of Mifepristone-Buccal Misoprostol Abortions up to 63 Days of Gestation in a Canadian Clinical Setting.
Warden S; Genkin I; Hum S; Dunn S
J Obstet Gynaecol Can; 2019 May; 41(5):647-652. PubMed ID: 31007171
[TBL] [Abstract][Full Text] [Related]
3. Effects of Legislation Regulating Abortion in Arizona.
Williams SG; Roberts S; Kerns JL
Womens Health Issues; 2018; 28(4):297-300. PubMed ID: 29631976
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of medical abortion using mifepristone and buccal misoprostol through 63 days.
Gatter M; Cleland K; Nucatola DL
Contraception; 2015 Apr; 91(4):269-73. PubMed ID: 25592080
[TBL] [Abstract][Full Text] [Related]
5. Medication abortion use among low-income and rural Texans before and during state-imposed restrictions and after FDA-updated labeling.
Goyal V; Brooks IHM; Wallace R; Dermish AI; Kumar B; Schutt-Ainé A; Beasley A; Aiken ARA; Potter JE
Am J Obstet Gynecol; 2020 Aug; 223(2):236.e1-236.e8. PubMed ID: 32109462
[TBL] [Abstract][Full Text] [Related]
6. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
Guest J; Chien PF; Thomson MA; Kosseim ML
BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893
[TBL] [Abstract][Full Text] [Related]
7. Termination of early pregnancy using flexible, low-dose mifepristone-misoprostol regimens.
Heikinheimo O; Leminen R; Suhonen S
Contraception; 2007 Dec; 76(6):456-60. PubMed ID: 18061704
[TBL] [Abstract][Full Text] [Related]
8. [The efficacy and acceptability of mifepristone medical abortion with home administration misoprostol provided by private providers linked with the hospital: a prospective study of 433 patients].
Faucher P; Baunot N; Madelenat P
Gynecol Obstet Fertil; 2005 Apr; 33(4):220-7. PubMed ID: 15894206
[TBL] [Abstract][Full Text] [Related]
9. Motivations for using misoprostol for abortion outside the formal healthcare system in Colombia: a qualitative study of women seeking postabortion care in Bogotá and the Coffee Axis.
Ortiz J; Blades N; Prada E
Reprod Health; 2024 Jun; 21(1):76. PubMed ID: 38824533
[TBL] [Abstract][Full Text] [Related]
10. Rebound of medication abortion in Texas following updated mifepristone label.
Baum SE; White K; Hopkins K; Potter JE; Grossman D
Contraception; 2019 May; 99(5):278-280. PubMed ID: 30684470
[TBL] [Abstract][Full Text] [Related]
11. Feasibility and effectiveness of unintended pregnancy prevention with low-dose mifepristone combined with misoprostol before expected menstruation.
Li CL; Chen DJ; Deng YF; Song LP; Mo XT; Liu KJ
Hum Reprod; 2015 Dec; 30(12):2794-801. PubMed ID: 26405260
[TBL] [Abstract][Full Text] [Related]
12. Sociodemographic Characteristics of Women Able to Obtain Medication Abortion Before and After Ohio's Law Requiring Use of the Food and Drug Administration Protocol.
Upadhyay UD; Johns NE; Cartwright AF; Franklin TE
Health Equity; 2018; 2(1):122-130. PubMed ID: 30283858
[No Abstract] [Full Text] [Related]
13. The impact of Mississippi's mandatory delay law on abortions and births.
Joyce T; Henshaw SK; Skatrud JD
JAMA; 1997 Aug; 278(8):653-8. PubMed ID: 9272897
[TBL] [Abstract][Full Text] [Related]
14. Medical management of unwanted pregnancy in France: modalities and outcomes. The aMaYa study.
Nisand I; Bettahar K;
Eur J Obstet Gynecol Reprod Biol; 2015 Jan; 184():13-8. PubMed ID: 25462213
[TBL] [Abstract][Full Text] [Related]
15. Medical abortion: overview and management.
Trupin SR; Moreno C
Medscape Womens Health; 2001 Dec; 6(6):4. PubMed ID: 11965218
[TBL] [Abstract][Full Text] [Related]
16. WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion.
Honkanen H; Piaggio G; Hertzen H; Bártfai G; Erdenetungalag R; Gemzell-Danielsson K; Gopalan S; Horga M; Jerve F; Mittal S; Thi Nhu Ngoc N; Peregoudov A; Prasad RN; Pretnar-Darovec A; Shah RS; Song S; Tang OS; Wu SC;
BJOG; 2004 Jul; 111(7):715-25. PubMed ID: 15198763
[TBL] [Abstract][Full Text] [Related]
17. Medical abortion practices: a survey of National Abortion Federation members in the United States.
Wiegerinck MM; Jones HE; O'Connell K; Lichtenberg ES; Paul M; Westhoff CL
Contraception; 2008 Dec; 78(6):486-91. PubMed ID: 19014795
[TBL] [Abstract][Full Text] [Related]
18. Change in Second-Trimester Abortion After Implementation of a Restrictive State Law.
White K; Baum SE; Hopkins K; Potter JE; Grossman D
Obstet Gynecol; 2019 Apr; 133(4):771-779. PubMed ID: 30870293
[TBL] [Abstract][Full Text] [Related]
19. Prospective study of home use of mifepristone and misoprostol for medical abortion up to 10weeks of pregnancy in Kazakhstan.
Platais I; Tsereteli T; Grebennikova G; Lotarevich T; Winikoff B
Int J Gynaecol Obstet; 2016 Sep; 134(3):268-71. PubMed ID: 27352735
[TBL] [Abstract][Full Text] [Related]
20. How Effective Is Misoprostol Alone for Medication Abortion?
Moseson H; Jayaweera R; Baum SE; Gerdts C
NEJM Evid; 2024 Jun; 3(6):EVIDccon2300129. PubMed ID: 38804786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
